Trial · NCT05962255
Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure
NCT05962255, Phase 3, Completed, Wroclaw Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure. Trials, record NCT05962255. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05962255
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure
- NCT number
- NCT05962255
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 50 participants, actual
- Lead sponsor
- Wroclaw Medical University
- Conditions
- Acute Heart Failure, Congestion, Heart Failure
- Interventions
- Furosemide intravenous infusion, Continous intravenous infusion of 0.9% Sodium Chloride solution, Continous intravenous infusion of 5% Glucose solution
- First posted
- 2023-07-27
- Last updated
- 2024-06-21
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Urine volume change at individual timepoints during first day of the procedure. | 24 hours | Comparison of urine volume between the groups at individual timepoints during the first day of the procedure. |
| Primary | Urine volume change at individual timepoints during second day of the procedure. | 48 hours | Comparison of urine volume between the groups at individual timepoints during the second day of the procedure. |
| Primary | Urine composition at individual time points. | 72 hours | Comparison of urine composition (urinary sodium and urinary chloride) between the groups and its change during 72h |
| Primary | Cumulative urine output at 24 hours. | 24 hours | Comparison of cumulative urine output between the groups at 24 hours. |
| Primary | Cumulative urine output at hours. | 48 hours | Comparison of cumulative urine output between the groups at 48 hours. |
| Primary | Total dose of furosemide. | 48 hours | Comparison of the total dose of furosemide between the groups at hours. |
| Secondary | Total time on intravenous furosemide. | 3 months | The total time on intravenous furosemide between hospital admission and discharge will be calculated. |
| Secondary | Renin-Angiotensin-Aldosterone system activity. | 24 hours | Comparison of the renin and aldosterone serum levels between the groups at the 24 hours. |
| Secondary | Renin-Angiotensin-Aldosterone system activity. | 48 hours | Comparison of the renin and aldosterone serum levels between the groups at the 48 hours. |
| Secondary | Heart Failure rehospitalization | 30 days | Compare the need for Heart Failure rehospitalization within 30 days. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 40455066 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05962255
GET https://conductscience.org/api/trials/v1/NCT05962255/registered